The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections

被引：1
|
作者：
Chopra, Teena [1 ]
机构：
[1] Wayne State Univ, Dept Infect Dis, Detroit, MI 48201 USA
来源：
INFECTIOUS DISEASES AND THERAPY | 2021年 / 10卷 / 02期
关键词：
Carbapenem-resistant organisms; Meropenem-vaborbactam; Multidrug-resistant organisms; Vabomere;
D O I：
10.1007/s40121-021-00421-x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：633 / 635
页数：3
相关论文
共 50 条
  • [1] The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
    Teena Chopra
    Infectious Diseases and Therapy, 2021, 10 : 633 - 635
  • [2] Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae
    Mouktaroudi, Maria
    Kotsaki, Antigone
    Giamarellos-Bourboulis, Evangelos J.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 809 - 818
  • [3] In-vitro activity of plazomicin, meropenem-vaborbactam, and omadacycline against carbapenem-resistant Gram-negative isolates in Egypt
    Gadallah, Mona Abd El-Aziz
    El-sayed, Wasila Moursy
    Hussien, Mohammed Zakaria
    Elheniedy, Mohammed Ahmed
    Maxwell, Sara Youssef
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (03) : 205 - 218
  • [4] Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
    Alosaimy, Sara
    Lagnf, Abdalhamid M.
    Morrisette, Taylor
    Scipione, Marco R.
    Zhao, Jing J.
    Jorgensen, Sarah C. J.
    Mynatt, Ryan
    Carlson, Travis J.
    Jo, Jinhee
    Garey, Kevin W.
    Allen, David
    DeRonde, Kailynn
    Vega, Ana D.
    Abbo, Lilian M.
    Venugopalan, Veena
    Athans, Vasilios
    Saw, Stephen
    Claeys, Kimberly C.
    Miller, Mathew
    Molina, Kyle C.
    Veve, Michael
    Kufel, Wesley D.
    Amaya, Lee
    Yost, Christine
    Ortwine, Jessica
    Davis, Susan L.
    Rybak, Michael J.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [5] Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections
    Shields, Ryan K.
    McCreary, Erin K.
    Marini, Rachel, V
    Kline, Ellen G.
    Jones, Chelsea E.
    Hao, Binghua
    Chen, Liang
    Kreiswirth, Barry N.
    Doi, Yohei
    Clancy, Cornelius J.
    Nguyen, M. Hong
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (03) : 667 - 671
  • [6] Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria
    Patel, Twisha S.
    Pogue, Jason M.
    Mills, John P.
    Kaye, Keith S.
    FUTURE MICROBIOLOGY, 2018, 13 (09) : 971 - 983
  • [7] Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
    Ackley, Renee
    Roshdy, Danya
    Meredith, Jacqueline
    Minor, Sarah
    Anderson, William E.
    Capraro, Gerald A.
    Polk, Christopher
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [8] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Bhowmick, Tanaya
    Weinstein, Melvin P.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (04) : 757 - 767
  • [9] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Tanaya Bhowmick
    Melvin P. Weinstein
    Infectious Diseases and Therapy, 2020, 9 : 757 - 767
  • [10] In vitro susceptibility of nonfermenting Gram-negative rods to meropenem-vaborbactam and delafloxacin
    Farfour, Eric
    d'Epenoux, Louise Ruffier
    Muggeo, Anaelle
    Alauzet, Corentine
    Cremet, Lise
    Moussalih, Sophie
    Roux, Antoine
    de Verdiere, Sylvie C.
    Bosphore, Amelie
    Corvec, Stephane
    Guillard, Thomas
    Vasse, Marc
    FUTURE MICROBIOLOGY, 2022, 18 (02) : 117 - 126
12345